8-K: QT Imaging Secures $155K Private Placement, Chairman Invests

QT Imaging Holdings, Inc. announced a private placement of common stock and warrants, raising approximately $155,002, with participation from its Chairman, Dr. Avi Katz, for working capital purposes.

Summary

• QT Imaging Holdings, Inc. (the "Company") completed a private placement on January 22, 2026, raising approximately $155,002 in gross proceeds.
• The placement involved the issuance of 24,107 shares of common stock and warrants to purchase an additional 48,214 shares of common stock.
• The purchase price per share was $6.43, representing 110% of the 5-day volume-weighted trading price for the Common Stock on January 22, 2026. The per share exercise price of the warrants is also $6.43.
• Dr. Avi Katz, the Chairman of the Company's Board of Directors, was the purchaser in this January 2026 Private Placement.
• The Company intends to use the net proceeds from this offering for working capital purposes.
• A Registration Rights Agreement was entered into, obligating the Company to file a registration statement for the resale of these securities within 30 calendar days and to have it declared effective by the SEC within 60 to 90 calendar days.
• The filing also references a previous October 2025 Private Placement that generated approximately $18,180,655 in gross proceeds and the repayment of $5.0 million of long-term debt, plus $360,477 in accrued interest and premium, to Lynrock Lake Master Fund LP on October 6, 2025.
• Unaudited pro forma condensed consolidated financial statements for the nine months ended September 30, 2025, were furnished, reflecting these transactions as if they had occurred on January 1, 2025.

Sentiment

Score: 6

Explanation: The filing reports a capital raise and debt repayment, which are generally positive for liquidity and balance sheet health. Insider participation is a positive signal of confidence. However, the January 2026 raise is relatively small, and the company's pro forma net loss remains significant, indicating ongoing operational challenges and a need for continuous funding.

Positives

• Successfully raised approximately $155,002 in gross proceeds through a private placement, contributing to liquidity.
• The Chairman of the Board, Dr. Avi Katz, participated in the private placement, signaling insider confidence in the Company's prospects.
• Proceeds are explicitly designated for working capital, which is crucial for supporting ongoing operations and strategic initiatives.
• The Company previously secured a significant capital infusion of approximately $18.18 million in October 2025 and repaid $5.0 million in long-term debt, improving the balance sheet and reducing financial obligations.

Negatives

• The private placement involves the issuance of new shares and warrants, which will result in dilution for existing shareholders.
• The relatively small amount of capital raised in the January 2026 placement ($155,002) compared to the October 2025 placement ($18.18 million) might suggest a more limited or specific funding need, or challenges in securing larger amounts.
• The need for successive capital raises (October 2025 and January 2026) indicates ongoing funding requirements to support operations and growth, which could put pressure on future financing efforts.

Risks

• Ability to sell and deploy the QT Imaging Breast Acoustic CT Scanner.
• Ability to extend product offerings into new areas or products.
• Ability to commercialize technology.
• Unexpected occurrences that deter the full documentation and bring to market plan for products.
• Trends and fluctuations in the industry.
• Changes in demand and purchasing volume of customers.
• Unpredictability of suppliers.
• Ability to attract and retain qualified personnel and the ability to move product sales to production levels.
• Changes in domestic and foreign business, market, financial, political, and legal conditions.
• Uncertainty of projected financial information.
• Delays caused by factors outside of our control.
• Changes in our ability to successfully receive purchase orders and generate revenue under our existing contracts with partners and distributors.
• Ability to realize the benefits of strategic partnerships.
• Identified material weakness in internal controls over financial reporting (including the timeline to remediate the material weakness).
• Rollout of the business and the timing of expected business milestones.
• Effects of competition on our future business.
• Ability to obtain and access financing in the future.
• Ability to pay our debt obligations as they come due.

Future Outlook

The Company intends to use the net proceeds from the January 2026 private placement for working capital purposes. It also plans to file a registration statement for the resale of the newly issued securities. The filing includes standard forward-looking statements regarding the ability to sell and deploy its QT Imaging Breast Acoustic CT Scanner, extend product offerings, commercialize technology, and manage various business, market, financial, political, and legal conditions. The Company's expectations, hopes, beliefs, intentions, plans, prospects, or strategies regarding its future business plans are subject to various risks and uncertainties.

Management Comments

• The Company intends to use the net proceeds from the offering for working capital purposes.

Industry Context

The filing does not provide specific industry context beyond the company's stated business of the QT Imaging Breast Acoustic CT Scanner. The capital raises suggest a growth-stage company requiring funding for operations and commercialization in the medical imaging sector, which is typically capital-intensive.

Corporate Governance

Related Party Transactions

• Dr. Avi Katz, the Chairman of the Company's Board of Directors, was the purchaser in the January 2026 Private Placement, acquiring 24,107 shares of common stock and warrants to purchase an additional 48,214 shares for approximately $155,002.

Stakeholder Impact

• Shareholders: Potential dilution from the issuance of new shares and warrants. However, the capital raise provides funding for operations, which could support long-term value.
• Creditors: The repayment of $5.0 million in long-term debt to Lynrock Lake Master Fund LP improves the company's debt profile and reduces financial risk.
• Employees/Operations: Proceeds for working capital can support ongoing business operations, including research and development, and selling, general, and administrative expenses, potentially ensuring job stability and operational continuity.

Next Steps

• File a registration statement covering the resale of the January 2026 Securities no later than the 30th calendar day following January 22, 2026.
• Have the registration statement declared effective by the SEC as promptly as practicable, but no later than 60 calendar days (or 90 days in case of full SEC review) following January 22, 2026.
• Use net proceeds from the January 2026 Private Placement for working capital purposes.

Key Dates

Recommendation

The company successfully raised capital and reduced debt, which are positive for its financial stability. Insider participation in the private placement signals confidence. However, the company continues to report significant net losses on a pro forma basis, indicating ongoing challenges in achieving profitability. The small size of the latest capital raise compared to previous ones suggests a more targeted or limited funding need, but the overall financial health still requires careful monitoring. Investors should hold to observe progress on commercialization and financial performance.

Keywords

QT Imaging Holdings, QTI, Private Placement, Common Stock, Warrants, Capital Raise, Working Capital, SEC Filing, Form 8-K, Dr. Avi Katz, Financial Reporting, Breast Acoustic CT Scanner, Medical Imaging, Corporate Governance